Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Rohit Nalamasu"'
Publikováno v:
Pain and Therapy, Vol 9, Iss 2, Pp 453-466 (2020)
Abstract Chronic pain management during the coronavirus disease 2019 (COVID-19) pandemic is a challenging process, especially with growing evidence that COVID-19 infection is associated with myalgias, referred pain, and widespread hyperalgesia. In li
Externí odkaz:
https://doaj.org/article/6217c7a48cb84fc988bf1b197065d02c
Autor:
Raj Vuppalanchi, Tiebing Liang, Chirayu Pankaj Goswami, Rohit Nalamasu, Lang Li, David Jones, Rongrong Wei, Wanqing Liu, Vishal Sarasani, Sarath Chandra Janga, Naga Chalasani
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74471 (2013)
Liver cirrhosis is associated with decreased hepatic cytochrome P4503A (CYP3A) activity but the pathogenesis of this phenomenon is not well elucidated. In this study, we examined if certain microRNAs (miRNA) are associated with decreased hepatic CYP3
Externí odkaz:
https://doaj.org/article/42e0f372ad1b41b7910d9ea0dd8242ef
Autor:
Joseph V. Pergolizzi, Salah N. El-Tallawy, Jo Ann LeQuang, Paul J. Christo, Rohit Nalamasu, Gehan I. Salem
Publikováno v:
Pain and Therapy. 10:181-209
Musculoskeletal pain is a challenging condition for both patients and physicians. Many adults have experienced one or more episodes of musculoskeletal pain at some time of their lives, regardless of age, gender, or economic status. It affects approxi
Autor:
Robert B. Raffa, Giustino Varrassi, Maninder Chopra, Frank Breve, Charles Wollmuth, Joseph V. Pergolizzi, Antonella Paladini, Rohit Nalamasu, Robert W. Taylor, Jo Ann LeQuang, Peter Magnusson, Paul J. Christo
Publikováno v:
Postgraduate Medicine
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Neurological manifestations are increasingly reported in a subset of COVID-19 patients. Previous infections related to coronaviruses, namely Severe Acute Respiratory Syndrome (SARS) and Middle Eastern Respiratory Syndrome (MERS) also appeared to have
Autor:
Rohit Nalamasu, Peter Magnusson, Joseph V. Pergolizzi, Jo Ann LeQuang, Frank Breve, Lucas Stolle, Giustino Varrassi
Publikováno v:
Advances in Therapy
Advances in therapy, 37(11):4481–4490
Advances in therapy, 37(11):4481–4490
In the light of the COVID-19 pandemic, anti-vaccine sentiments have been on the rise, with a recent seminal study on the development of anti-vaccine views in social media even making its way into Nature Communications. Yet, with the current scientifi
Publikováno v:
Pain and Therapy, Vol 9, Iss 2, Pp 453-466 (2020)
Pain and Therapy
Pain and Therapy
Chronic pain management during the coronavirus disease 2019 (COVID-19) pandemic is a challenging process, especially with growing evidence that COVID-19 infection is associated with myalgias, referred pain, and widespread hyperalgesia. In light of th
Autor:
Srinivas Nalamachu, Rohit Nalamasu
Publikováno v:
Physical Medicine and Rehabilitation Clinics of North America. 31:205-217
The Chronic pain epidemic is a pressing public health crises facing the United States. Currently, more than 100 million Americans suffer from chronic pain, with chronic pain being among the most prevalent conditions and the leading cause of disabilit
Autor:
Josh Wales, Jo Ann LeQuang, Scot Rosko, Joseph V. Pergolizzi, Caitlin Smarelli, Lucas Stolle, Robert W. Rodenbeck, Kyle R. Davidson, Rohit Nalamasu
Publikováno v:
Cureus
OBJECTIVE: Personal protective equipment (PPE) is urgently sought during public health crises. It is necessary for the safety of both the patient and the healthcare professional. Yet during the recent COVID-19 pandemic, PPE scarcity in many countries
Autor:
Michael Cirullo, Marc C. Torjman, Alexander Olson, Lucas Stolle, Eugene R. Viscusi, Rohit Nalamasu, Joseph V. Pergolizzi, Eric S. Schwenk, Irving W. Wainer, Basant Pradhan
Publikováno v:
Current Pain and Headache Reports. 25
Autor:
Eugene R. Viscusi, Basant Pradhan, Rohit Nalamasu, Michael Cirullo, Joseph V. Pergolizzi, Irving W. Wainer, Alexander Olsen, Marc C. Torjman, Lucas Stolle, Eric S. Schwenk
Publikováno v:
Current Pain and Headache Reports. 25
While ketamine’s analgesia has mostly been attributed to antagonism of N-methyl-d-aspartate receptors, evidence suggests multiple other pathways are involved in its antidepressant and possibly analgesic activity. These mechanisms and ketamine’s r